CELZ vs. TTNP, PALI, FRTX, NSTGQ, TCON, SRNE, ALBT, TCBP, IKT, and FNCH
Should you be buying Creative Medical Technology stock or one of its competitors? The main competitors of Creative Medical Technology include Titan Pharmaceuticals (TTNP), Palisade Bio (PALI), Fresh Tracks Therapeutics (FRTX), NanoString Technologies (NSTGQ), TRACON Pharmaceuticals (TCON), Sorrento Therapeutics (SRNE), Avalon GloboCare (ALBT), TC Biopharm (TCBP), Inhibikase Therapeutics (IKT), and Finch Therapeutics Group (FNCH). These companies are all part of the "biological products, except diagnostic" industry.
Creative Medical Technology (NASDAQ:CELZ) and Titan Pharmaceuticals (NASDAQ:TTNP) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, earnings, media sentiment, institutional ownership, community ranking, risk and dividends.
1.4% of Creative Medical Technology shares are held by institutional investors. Comparatively, 31.5% of Titan Pharmaceuticals shares are held by institutional investors. 3.3% of Creative Medical Technology shares are held by company insiders. Comparatively, 24.9% of Titan Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Creative Medical Technology has a net margin of 0.00% compared to Titan Pharmaceuticals' net margin of -2,014.71%. Creative Medical Technology's return on equity of -46.50% beat Titan Pharmaceuticals' return on equity.
Creative Medical Technology has a beta of 2.22, meaning that its share price is 122% more volatile than the S&P 500. Comparatively, Titan Pharmaceuticals has a beta of 1.32, meaning that its share price is 32% more volatile than the S&P 500.
Titan Pharmaceuticals received 264 more outperform votes than Creative Medical Technology when rated by MarketBeat users. However, 68.93% of users gave Creative Medical Technology an outperform vote while only 57.07% of users gave Titan Pharmaceuticals an outperform vote.
Creative Medical Technology has higher earnings, but lower revenue than Titan Pharmaceuticals. Creative Medical Technology is trading at a lower price-to-earnings ratio than Titan Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.
In the previous week, Creative Medical Technology had 4 more articles in the media than Titan Pharmaceuticals. MarketBeat recorded 7 mentions for Creative Medical Technology and 3 mentions for Titan Pharmaceuticals. Creative Medical Technology's average media sentiment score of 1.23 beat Titan Pharmaceuticals' score of 0.85 indicating that Creative Medical Technology is being referred to more favorably in the media.
Summary
Creative Medical Technology beats Titan Pharmaceuticals on 10 of the 15 factors compared between the two stocks.
Get Creative Medical Technology News Delivered to You Automatically
Sign up to receive the latest news and ratings for CELZ and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CELZ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Creative Medical Technology Competitors List
Related Companies and Tools
